In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3548-3553

  Bayer, Arnold S ^a,b   Prasad, Rajendra ^c   Chandra, Jyotsna ^c   Koul, Anjni ^c   Smriti, M ^c   Varma, Archana ^c   Skurray, Ronald A ^d   Firth, Neville ^d   Brown, Melissa H ^d   Koo, S U Pin ^a   Yeaman, Michael R ^a,b  

^a St John's Cardiovascular Research Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JAWAHARLAL NEHRU UNIVERSITY   (India)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; FATTY ACID; THROMBIN;

AMINO ACID TRANSPORT; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL MEMBRANE FLUIDITY; ENDOCARDITIS; FLUORESCENCE POLARIZATION; HYDROPHOBICITY; LIPID COMPOSITION; MEMBRANE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

AMINO ACIDS; ANTI-BACTERIAL AGENTS; BETA-THROMBOGLOBULIN; BIOLOGICAL TRANSPORT; BLOOD PROTEINS; CELL MEMBRANE; CHEMOKINES; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MICROBIAL; FATTY ACIDS; MEMBRANE FLUIDITY; MUTAGENESIS, INSERTIONAL; PHENOTYPE; PHOSPHOLIPIDS; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS;

EID: 0034128095     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3548-3553.2000     Document Type: Article

References (48)

1. Bayer, A. S., D. Cheng, M. R. Yeaman, G. R. Corey, R. S. McClelland, L. J. Harrell, and V. G. Fowler. 1998. In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob. Agents Chemother. 42:3169-3172.
2. Bechinger, B., M. Zasloff, and S. J. Opella. 1993. Structure and orientation of the antibiotic peptide, magainin, in membranes by solid-state nuclear magnetic resonance spectroscopy. Protein Sci. 2:2077-2084.
3. Cohen, M. L. 1992. Epidemiology of drug resistance: implications for a post-antibiotic era. Science 257:1050-1055.
4. Dankert, J., J. van der Werff, S. A. Zaat, W. Joldersma, D. Klein, and J. Hess. 1995. Involvement of bacterial factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect. Immun. 63:663-671.
5. Dhawan, V. K., A. S. Bayer, and M. R. Yeaman. 1998. Influence of in vitro susceptibility to thrombin-induced platelet microbicidal protein on the progression and hematogenous dissemination of experimental Staphylococcus aureus endocarditis. Infect. Immun. 66:3476-3479.
6. Dhawan, V. K., M. R. Yeaman, A. L. Cheung, E. Kim, P. M. Sullam, and A. S. Bayer. 1997. Phenotypic resistance to platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect. Immun. 65:3293-3299.
7. Drake, T. A., and M. Pang. 1988. Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J. Infect. Dis. 157: 749-756.
8. Ganz, T., M. E. Selsted, and R. I. Lehrer. 1990. Defensins. Eur. J. Haematol 44:1-8.
9. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
10. Ing, M. B., L. M. Baddour, and A. S. Bayer. 1997. Bacteremia and infective endocarditis: pathogenesis, diagnosis and complications, p. 331-354. In K. B. Crossley and G. L. Archer (ed.), The staphylococci in human diseases. Churchill-Livingstone, New York, N.Y.
11. Kinosta, K. 1981. Dynamic structure of biologic membranes as probed by DPH: a nanosecond fluorescence depolarization study. Biochemistry 20: 4270-4277.
12. Koo, S.-P., A. S. Bayer, H.-G. Sahl, R. A. Proctor, and M. R. Yeaman. 1996. Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect. Immun. 64:3758-3764.
13. Koo, S.-P., A. S. Bayer, B. L. Kagan, and M. R. Yeaman. 1999. Membrane permeabilization by thrombin-induced platelet microbicidal protein-1 is modulated by transmembrane voltage orientation and magnitude. Infect. Immun. 67:2475-2481.
14. Koo, S.-P., M. R. Yeaman, C. C. Nast, and A. S. Bayer. 1997. The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein. Infect. Immun. 65:4795-4800.
15. Krishnamurthy, S., U. Chatterjee, V. Gupta, R. Prasad, P. Das, P. Snehlata, S. E. Hasnain, and R. Prasad. 1998. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in a Baculovirus expression system. Yeast 14:535-550.
16. Krishnamurthy, S., V. Gupta, R. Prasad, S. L. Panwar, and R. Prasad. 1998. Expression of CDR1, a multidrug resistance of Candida albicans: in vitro transcriptional activation by heat shock, drugs and human steroid hormones. FEMS Microbiol. Lett. 160:191-197.
17. Kupferwasser, L. I., R. A. Skurray, M. H. Brown, N. Firth, M. R. Yeaman, and A. S. Bayer. 1999. Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus. Antimicrob. Agents Chemother. 43:2395-2399.
18. Lundbaek, J. A., P. Birn, J. Girshman, A. J. Hansen, and O. S. Andersen. 1996. Membrane stiffness and channel function. Biochemistry 35:3825-3830.
19. Lyon, B. R., J. W. May, and R. A. Skurray. 1984. Tn 4001: a gentamicin and kanamycin resistance transposon in Staphylococcus aureus. Mol. Gen. Genet. 193:554-556.
20. Mishra, P., and R. Prasad. 1987. Alterations in fatty acyl composition can selectively affect amino acid transport in Saccharomyces cerevsiae. Biochem. Int. 15:499-508.
21. Mitchell, B. A., M. H. Brown, and R. A. Skurray. 1998. QacA multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanides, and guanylhydrazones. Antimicrob. Agents Chemother. 42:475-477.
22. Ojcius, D. M., and J. D. E. Young. 1991. Cytolytic pore-forming proteins and peptides: is there a common structural motif? Trends Biochem. Sci. 16: 225-229.
23. Otto, M., A. Peschel, and F. Götz. 1998. Producer self-protection against the lantibiotic epidermin by the ABC transporter EpiFEG of Staphylococcus epidermidis. FEMS Microbiol. Lett. 166:203-211.
24. Parkinson, T., D. J. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida albicans. Antimicrob. Agents Chemother. 39:1696-1699.
25. Paulsen, I. T., M. H. Brown, T. J. Littlejohn, B. A. Mitchell, and R. A. Skurray. 1996. Multidrug resistance proteins QacA and OacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. USA 93:3630-3635.
26. Peschel, A., and F. Götz. 1996. Analysis of the Staphylococcus epidermidis genes, epiF, -E, and -G, involved in epidermin immunity. J. Bacteriol. 178: 531-536.
27. Pittet, D., and R. P. Wenzel. 1995. Nosocomial blood stream infections: secular trends in rates, mortality and contribution to total hospital deaths. Arch. Intern. Med. 155:1177-1184.
28. Prasad, R. 1987. Nutrient transport in Candida albicans, a pathogenic yeast. Yeast 3:209-221.
29. Prasad, R. (ed.). 1991. Candida albicans - cellular and molecular biology, p. 128-143. Springer-Verlag, Berlin, Germany.
30. Prasad, R., D. F. Phillipes, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
31. Rao, L. R. S., D. S. Prasad, and R. Prasad. 1986. Transport of basic amino acids in Candia albicans. Biochim. Biophys. Acta 856:237-243.
32. Rouch, D. A., M. E. Byrne, Y. C. Kong, and R. A. Skurray. 1987. The aacA-aphD gentamicin and kanamycin resistance determinant of Tn4001 from Staphylococcus aureus: expression and nucleotide sequence analysis. J. Gen. Microbiol. 133:3039-3052.
33. Rouch, D. A., D. S. Cram, D. DiBerardino, T. G. Littlejohn, and R. A. Skurray. 1990. Efflux-mediated antiseptic resistance gene qacA, from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteins. Mol. Microbiol. 4:2051-2062.
34. Rouch, D. A., L. J. Messerotti, L. S. L. Loo, C. A. Jackson, and R. A. Skurray. 1989. Trimethoprim resistance transposon, Tn4003, from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257. Mol. Microbiol. 3:161-175.
35. Ruhr, E., and H. G. Sahl. 1985. Mode of action of the peptide antibiotic nisin, and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob. Agents Chemother. 27:841-845.
36. Shafer, W. M., X.-D. Qu, A. J. Waring, and R. I. Lehrer. 1998. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA 95:1829-1833.
37. Shinitsky, M., and Y. Barenholz. 1978. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim. Biophys. Acta 515:367-394.
38. Speert, D. P., B. A. Loh, D. A. Cabral, and I. E. Salit. 1986. Nonopsonic phagocytosis of nonmucoid Pseudomonas aeruginosa by human neutrophils and monocyte-derived macrophages is correlated with bacterial piliation and hydrophobicity. Infect. Immun. 53:207-212.
39. Stubbs, C. D., and A. D. Smith. 1984. The modification of mammalian polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim. Biophys. Acta 77:89-137.
40. Tang, Y. Q., M. R. Yeaman, and M. E. Selsted. 1995. Purification, characterization, and antimicrobial properties of peptides released from thrombin-induced human platelets. Blood 86:556a. (Abstract 3626.)
41. Tennent, J. M., B. R. Lyon, M. T. Gillespie, J. W. May, and R. A. Skurray. 1985. Cloning and expression of Staphylococcus aureus plasmid-mediated quaternary ammonium resistance in Escherichia coli. Antimicrob. Agents Chemother. 27:79-83.
42. Van-Blitterswijk, W. J., B. W. Van der Meer, and H. Hilkmann. 1987. Quantitative contributions of cholesterol and the individual classes of phospholipids and their degree of fatty acyl unsaturation to membrane fluidity measured by fluorescence polarization. Biochemistry 26:1746-1757.
43. Wu, T., M. R. Yeaman, and A. S. Bayer. 1994. In vitro resistance to platelet microbicidal protein correlates with endocarditis source among staphylcoccal isolates. Antimicrob. Agents Chemother. 38:729-732.
44. Yeaman, M. R. 1997. The role of platelets in antimicrobial host defense. Clin. Infect. Dis. 25:951-970.
45. Yeaman, M. R., A. S. Bayer, S.-P. Koo, W. Foss, and P. M. Sullam. 1998. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J. Clin. Investig. 101:178-187.
46. Yeaman, M. R., S. M. Puentes, D. C. Norman, and A. S. Bayer. 1992. Partial purification and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect. Immun. 60:1202-1209.
47. Yeaman, M. R., A. Shen, Y. Tang, A. S. Bayer, and M. A. Selsted. 1997. Purification and in vitro activities of platelet microbicidal proteins. Infect. Immun. 65:1023-1031
48. Yeaman, M. R., P. M. Sullam, P. F. Dazin, and A. S. Bayer. 1994. Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro. Infect. Immun. 62: 3416-3423.